Pulmonary Hypertension Clinical Trials in New York, New York

7 studies are recruiting for pulmonary hypertension in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

   MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Weill Cornell University Medical College, New York, New York

   Locations

   41 in total

   Run by

   Tempus AI

   See if you can join NCT06911632 on ClinicalTrials.gov

2. Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

   The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   USA005, New York, New York

   Locations

   186 in total

   Run by

   Insmed Incorporated

   See if you can join NCT07179380 on ClinicalTrials.gov

3. A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

   The goal of this clinical study is to evaluate the safety and efficacy of percutaneous pulmonary artery denervation with the Multi-Pole Pulmonary Artery Radiofrequency Ablation Enhancor System in patients with combined pre- and post-capillary pulmonary hypertension (CpcPH) associated with left hear…

   Stage

   Not phased

   Ages

   18 to 85

   Site

   Mount Sinai Morningside, New York, New York

   Locations

   18 in total

   Run by

   Pulnovo Medical, Inc.

   See if you can join NCT07214376 on ClinicalTrials.gov

4. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

   This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

   Stage

   Not phased

   Ages

   18 and older

   Site

   New York University Langone Medical Center, New York, New York

   Locations

   71 in total

   Run by

   United Therapeutics

   See if you can join NCT06388421 on ClinicalTrials.gov

5. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

   The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

   Stage

   Not phased

   Ages

   18 and older

   Site

   New York-Presbyterian/Columbia University Medical Center, New York, New York

   Locations

   68 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT06526195 on ClinicalTrials.gov

6. Pulmonary Hypertension Association Registry

   The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

   Stage

   Not phased

   Ages

   0 and older

   Site

   Weill Cornell Medical Center, New York, New York

   Locations

   52 in total

   Run by

   Pulmonary Hypertension Association, Inc.

   See if you can join NCT04071327 on ClinicalTrials.gov

7. Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

   This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cornell University, New York, New York

   Locations

   12 in total

   Run by

   Aria CV, Inc

   See if you can join NCT04555161 on ClinicalTrials.gov